Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FWVTL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,416
Award facts
- Contract value 100% obligated
- $50,415.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $50,415.51, represents a competitive award with no set-aside designation and is scheduled for completion by November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical procurement infrastructure, particularly through its partnership with the Defense Logistics Agency. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This specific delivery order for XELJANZ XR supports the Defense Health Agency and other government healthcare systems' needs for rheumatoid arthritis and other immunological condition treatments through AmerisourceBergen's established distribution network.
Quick answers
Who was awarded contract SPE2DB26FWVTL?
SPE2DB26FWVTL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FWVTL worth?
The government has obligated $50,416 on SPE2DB26FWVTL.
Is contract SPE2DB26FWVTL an order under another contract?
Yes. SPE2DB26FWVTL is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB26FWVTL competed?
The extent of competition for SPE2DB26FWVTL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award